News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,615 Results
Type
Article (41561)
Company Profile (231)
Press Release (692813)
Multimedia
Podcasts (97)
Webinars (21)
Section
Business (204936)
Career Advice (2036)
Deals (35632)
Drug Delivery (134)
Drug Development (81614)
Employer Resources (173)
FDA (16551)
Job Trends (15002)
News (347041)
Policy (32758)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2608)
Accelerated approval (55)
ADA (44)
Adcomms (29)
Allergies (193)
Alliances (49583)
ALS (226)
Alzheimer's disease (1842)
Antibody-drug conjugate (ADC) (520)
Approvals (17036)
Artificial intelligence (727)
ASCO (327)
Autoimmune disease (347)
Automation (63)
Bankruptcy (364)
Best Places to Work (11635)
BIO (68)
BIOSECURE Act (20)
Biosimilars (235)
Biotechnology (149)
Bladder cancer (204)
Brain cancer (75)
Breast cancer (803)
Cancer (6324)
Cardiovascular disease (505)
Career advice (1733)
Career pathing (45)
CAR-T (355)
CDC (58)
Celiac Disease (3)
Cell therapy (965)
Cervical cancer (56)
Clinical research (71570)
Collaboration (2207)
Commercialization (1)
Company closure (5)
Compensation (1520)
Complete response letters (85)
COVID-19 (2754)
CRISPR (116)
C-suite (1245)
Cystic fibrosis (157)
Data (8666)
Decentralized trials (3)
Denatured (29)
Depression (174)
Dermatology (98)
Diabetes (667)
Diagnostics (7030)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (362)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (306)
Earnings (92233)
Editorial (68)
Employer branding (21)
Employer resources (155)
Events (120629)
Executive appointments (1132)
FDA (20591)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1857)
Gene editing (246)
Generative AI (62)
Gene therapy (750)
GLP-1 (1093)
Government (4752)
Grass and pollen (6)
Guidances (421)
Healthcare (19146)
Hematology (192)
HIV (90)
Huntington's disease (62)
IgA nephropathy (113)
Immunology and inflammation (302)
Immuno-oncology (106)
Indications (222)
Infectious disease (3120)
Inflammatory bowel disease (222)
Inflation Reduction Act (14)
Influenza (142)
Intellectual property (320)
Interviews (321)
IPO (16680)
IRA (50)
Job creations (3650)
Job search strategy (1432)
JPM (58)
Kidney cancer (21)
Labor market (112)
Layoffs (576)
Leadership (42)
Legal (7954)
Liver cancer (103)
Longevity (35)
Lung cancer (836)
Lymphoma (477)
Machine learning (65)
Management (61)
Manufacturing (1160)
Marketing (4)
MASH (210)
Medical affairs (1)
Medical device (13999)
Medtech (14173)
Mergers & acquisitions (20275)
Metabolic disorders (1651)
mRNA (230)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (459)
Neuropsychiatric disorders (109)
Neuroscience (3479)
Neurotech (1)
NextGen: Class of 2026 (6524)
Non-profit (4539)
Now hiring (83)
Obesity (758)
Opinion (297)
Ovarian cancer (241)
Pain (266)
Pancreatic cancer (354)
Parkinson's disease (394)
Partnered (36)
Patents (643)
Patient recruitment (773)
Peanut (67)
People (59928)
Pharmaceutical (54)
Pharmacy benefit managers (33)
Phase 1 (22317)
Phase 2 (31535)
Phase 3 (23459)
Pipeline (9896)
Policy (331)
Postmarket research (2569)
Preclinical (9478)
Press Release (64)
Prostate cancer (336)
Psychedelics (57)
Radiopharmaceuticals (345)
Rare diseases (1184)
Real estate (5974)
Recruiting (71)
Regulatory (25850)
Reports (56)
Research institute (2424)
Resumes & cover letters (354)
Rett syndrome (46)
RNA editing (25)
RSV (90)
Schizophrenia (183)
Series A (315)
Series B (234)
Service/supplier (11)
Sickle cell disease (121)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (48)
Startups (3650)
State (2)
Stomach cancer (18)
Supply chain (134)
Tariffs (87)
The Weekly (66)
Vaccines (1152)
Venture capital (121)
Weight loss (483)
Women's health (138)
Worklife (21)
Date
Last 7 days (474)
Last 30 days (2006)
Last 365 days (30311)
2026 (16404)
2025 (30166)
2024 (35176)
2023 (40072)
2022 (51173)
2021 (55707)
2020 (54080)
2019 (46535)
2018 (35015)
2017 (32106)
2016 (31480)
2015 (37551)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (742)
Alabama (93)
Alaska (7)
Arizona (367)
Arkansas (14)
Asia (39955)
Australia (6550)
California (14038)
Canada (3974)
China (1496)
Colorado (598)
Connecticut (613)
Delaware (435)
Europe (86487)
Florida (2119)
Georgia (448)
Hawaii (3)
Idaho (63)
Illinois (1156)
India (99)
Indiana (633)
Iowa (25)
Japan (601)
Kansas (134)
Kentucky (51)
Louisiana (58)
Maine (76)
Maryland (1668)
Massachusetts (10060)
Michigan (377)
Minnesota (758)
Mississippi (6)
Missouri (149)
Montana (33)
Nebraska (30)
Nevada (150)
New Hampshire (84)
New Jersey (3675)
New Mexico (30)
New York (3690)
North Carolina (1770)
North Dakota (9)
Northern California (7099)
Ohio (420)
Oklahoma (23)
Oregon (41)
Pennsylvania (2790)
Puerto Rico (31)
Rhode Island (52)
South America (1113)
South Carolina (87)
South Dakota (2)
Southern California (5571)
Tennessee (231)
Texas (2252)
United States (49512)
Utah (418)
Vermont (2)
Virginia (344)
Washington D.C. (81)
Washington State (1115)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
734,615 Results for "nephros inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nephros Announces Financial Results for Quarter Ended March 31, 2026
May 8, 2026
·
10 min read
Press Releases
Nephros Schedules First Quarter 2026 Financial Results Conference Call
April 30, 2026
·
1 min read
Press Releases
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
March 13, 2026
·
12 min read
Press Releases
Nephros Announces Strong Second Quarter Financial Results
August 8, 2025
·
12 min read
Press Releases
Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History
November 6, 2025
·
12 min read
Press Releases
Nephros Schedules Second Quarter 2025 Financial Results Conference Call
July 31, 2025
·
1 min read
Business
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023.
March 7, 2024
·
12 min read
Business
Nephros Announces Results for Quarter Ended September 30, 2023
Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2023.
November 8, 2023
·
11 min read
Business
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.
February 29, 2024
·
1 min read
Press Releases
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026
·
12 min read
1 of 73,462
Next
